Mark E. Gurney

9.0k citations
71 papers · 5.7k · 3 hit papers · h-index 39

Impact in

    • Animal Vocal Communication and Behavior
  • Neurology top 0.5%
    • Amyotrophic Lateral Sclerosis Research
    • Parkinson's Disease Mechanisms and Treatments

Papers in

    • Phosphodiesterase function and regulation 22
    • Receptor Mechanisms and Signaling 12
    • Cholinesterase and Neurodegenerative Diseases 14
    • Inflammatory mediators and NSAID effects 6

Mark E. Gurney

70 papers receiving 5.5k citations

Mark E. Gurney's Hit Papers

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US 2024 · 81 citations
810+10+20Years since publication100200300400500

Peers

Mark E. Gurney
Comparison fields: 5 of 134
  • Developmental Biology 611
  • Neurology 1.6k
  • Genetics 834
  • Neurology 521
  • Pharmacology 919
Replace Leslie M. Thompson with:
Leslie M. Thompson United States
Hoon Ryu United States
Angelo Poletti Italy
James J. Cox United Kingdom
Rita De Gasperi United States
Michael Wong United States
John E. Pintar United States
Donald C. Lo United States
T. Conrad Gilliam United States
Frederick R. Taylor United States
Mark E. Gurney relative to Leslie M. Thompson United States Leslie M. Thompson's profile →
Citations per field
00.5×10×13.6×
Leslie M. Thompson · 1×
Citations per year

Countries citing papers authored by Mark E. Gurney

Since Specialization
Citations

This map shows the geographic impact of Mark E. Gurney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Gurney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Gurney more than expected).

Fields of papers citing papers by Mark E. Gurney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Gurney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Gurney. The network helps show where Mark E. Gurney may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Gurney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Gurney Line = papers co-authored together Mark E. Gurney links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis
Hit paper breakdown →
1996570
2 1980395
3 2001335
4 2009335
5 2001285
6 1998245
7 1997219
8 1981178
9
COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
Hit paper breakdown →
2021172
10 1982169
11 1997160
12 1998147
13 1998118
14 2020118
15 2009107
16 2014102
17 2009101
18 1984100
19 199792
20 202191

About Mark E. Gurney

Mark E. Gurney is a scholar working on Molecular Biology, Pharmacology, Neurology, Genetics and Neurology, having authored 71 papers that have together received 5.7k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (22 papers), Amyotrophic Lateral Sclerosis Research (14 papers), Cholinesterase and Neurodegenerative Diseases (14 papers), Receptor Mechanisms and Signaling (12 papers), Neurogenetic and Muscular Disorders Research (9 papers), Neurological diseases and metabolism (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). The work is most often cited by research in Developmental Biology (611 citations), Neurology (1.6k citations), Genetics (834 citations), Neurology (521 citations) and Pharmacology (919 citations). Mark E. Gurney has collaborated with scholars based in United States, Iceland and Australia. Frequent co-authors include Masakazu Konishi, Edward D. Hall, Paula K. Andrus, Alex B. Burgin, Timothy J. Fleck, Ping Zhai, Lawrence C Katz, Rong Xu, Adele M. Pauley and Jinhe Li. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Annals of Neurology, Journal of Medicinal Chemistry, Alzheimer s & Dementia and Journal of Neuropathology & Experimental Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact